ReviewEXCLI journal2024
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside.
Ali Hassanzadeh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewEXCLI journal2024
Ali Hassanzadeh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.